Product Information
TAFLUPROST 0.0015% EYE DROP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $2.4535 per EA under NDC 50742033930. Its NADAC has been published 78 times since Apr 9, 2025.
FDA first approved this application on Apr 5, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
.015 mg/mL
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742033930
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TAFLUPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA218002FDA Approved
4/5/2024
TE Code
AT
On Market Since
12/18/2024
Pharmacological Classes
Price Statistics
The NADAC for TAFLUPROST 0.0015% EYE DROP has been published 78 times since Apr 9, 2025, and over the history we have for it it has declined 32.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4535 per EA |
|---|---|
| All-time high | $3.6204 (Apr 16, 2025) |
| All-time low | $2.3815 (Jul 22, 2026) |
| 52-week high | $3.0301 |
| 52-week low | $2.3815 |
| Median price | $2.9595 |
| Average price | $2.9558 |
| Largest weekly change | -7.5% (Jun 17, 2026) |
| Weeks tracked | 78 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tafluprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAFLUPROST 0.0015% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TAFLUPROST 0.0015% EYE DROP, manufactured by Ingenus Pharmaceuticals LLC, is $2.4535 per EA (NDC 50742033930), effective Sep 30, 2026.
How has the price of TAFLUPROST 0.0015% EYE DROP changed over time?
Over the history we have for it, the NADAC for TAFLUPROST 0.0015% EYE DROP has declined 32.2%. It has been tracked across 78 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for TAFLUPROST 0.0015% EYE DROP?
Since Apr 9, 2025, the NADAC for TAFLUPROST 0.0015% EYE DROP has ranged from a low of $2.3815 (Jul 22, 2026) to a high of $3.6204 (Apr 16, 2025), with a median of $2.9595 per EA.
Are there cheaper alternatives to TAFLUPROST 0.0015% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TAFLUPROST 0.0015% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures TAFLUPROST 0.0015% EYE DROP?
TAFLUPROST 0.0015% EYE DROP (NDC 50742033930) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.